Fosun International Holds 2025 Annual Results Presentation: Fosun has the Ability to Navigate Through Cycles
HONG KONG, April 1, 2026 /PRNewswire/ -- On 31 March, Fosun International held its 2025 annual results presentation in Shanghai. Guo Guangchang, Chairman of Fosun International; Wang Qunbin, Co-Chairman of Fosun International; Chen Qiyu, Co-CEO of...
Guo Guangchang: Fosun International's NAV reaches HKD18.1 Per Share, Focusing Resources on Core, High‑Growth Areas
HONG KONG, March 31, 2026 /PRNewswire/ -- On the morning of 31 March, Guo Guangchang, Chairman of Fosun International, stated at Fosun International's 2025 annual results presentation that the RMB23.4 billion impairment provision was a "prudent...
CNOOC Limited Hits New Records of Reserves and Production in 2025, Profit Resilience Continues to Consolidate
HONG KONG, March 26, 2026 /PRNewswire/ -- CNOOC Limited (the "Company", SEHK: 00883 (HKD Counter) and 80883 (RMB Counter), SSE: 600938) today announced its 2025 annual results for the year ended December 31, 2025. Net production was approximately...
Henlius Reports 2025 Results: Sustained Growth in Both Revenue and Profit, Advancing Innovation Validation and Global Operations
SHANGHAI, March 20, 2026 /PRNewswire/ -- Henlius (2696.HK) today announced its annual results for the year ended December 31, 2025. During the reporting period, the Company recorded revenue of RMB 6.6666 billion, representing a year-on-year increase...
OCI Global Reports H2 2025 and FY 2025 Unaudited Results
AMSTERDAM, March 16, 2026 /PRNewswire/ -- Foreword Subsequent to the reporting period, geopolitical developments in the Middle East have led to an immediate and significant increase in European natural gas prices of approximately 60%, resulting in...
OPTRUST FULLY FUNDED FOR 17(TH) CONSECUTIVE YEAR
TORONTO, March 11, 2026 /PRNewswire/ -- Today, OPTrust released its 2025 Funded Status Report — Service & Security – Since 1995 — which details the Plan's financial results and funded status, while marking its 30th anniversary. In 2025, OPTrust...
Registrational Phase III AMPLIFY trial: Target number of participants achieved
SYDNEY, March 10, 2026 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with...
IFS CAPITAL 2025 RESULTS: FULL-YEAR NET PROFIT AT S$ 6.36 MILLION (+71.5% YOY)
The Board proposes a first and final one-tier tax-exempt dividend of 0.80 cents per ordinary share (+60% YoY) SINGAPORE, March 3, 2026 /PRNewswire/ -- In 2025, IFS achieved profit before tax of S$ 8.74 million and net profit after tax of S$ 6.36...
Golden Agri-Resources Sustains Strong Performance for Full Year 2025
Full-year revenue reached a record high at nearly US$13 billion, representing a 19% year-on-year increase. EBITDA for the year grew by 14% to reach US$1.26 billion, supported by an improved second-half performance. The Board has proposed an 18%...
THE ADECCO GROUP Q4 & FULL YEAR 2025 RESULTS
Strong share gains and solid growth; operating leverage and cashflow drive deleveraging ZURICH, Feb. 25, 2026 /PRNewswire/ -- AD HOC ANNOUNCEMENT pursuant to Art. 53 Listing Rules of SIX Swiss Exchange Q4 HIGHLIGHTS Further market share gains, Group...